EN
中文
Home
About us
About us
Board of Directors
Management Team
R&D and Manufacturing
Pipeline
Manufacturing Facility
Research and Development Capabilities
Strategic Partnerships
Investor Relations
Corporate Information
Announcements and Circulars
Financial Reports
Corporate Presentations
Corporate Governance
Investor Relations Contacts
News
Contact us
EN
中文
Home
About us
About us
Board of Directors
Management Team
R&D and Manufacturing
Pipeline
Manufacturing Facility
Research and Development Capabilities
Strategic Partnerships
Investor Relations
Corporate Information
Announcements and Circulars
Financial Reports
Corporate Presentations
Corporate Governance
Investor Relations Contacts
News
Contact us
From
To
Search
2024
2023
2024
全部
TOTAL:64 NEWS
Zhaoke Ophthalmology Successfully Recruited its First Patient for ZKY001 Phase II Clinical Trial
read
2020-12-24
1682
Zhaoke Hong Kong and PanOptica Entered Into License Agreement for PAN-90806
read
2020-12-01
1879
Conclusion of Series B Fundraising of Approximately US$145 Million for Zhaoke Ophthalmology Marks Big Step Towards Achieving Possible Spin-off and Separate Listing
read
2020-10-09
2100
Zhaoke Hong Kong and IACTA Entered Into License Agreement for IC-265 and IC-270
read
2020-07-01
1840
>
首页
9
10
11
12
13
尾页
Guangzhou Headquarters
Tel: 020-39062828
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
粤公网安备 44011502000975号
粤ICP备2022095718号
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
粤公网安备 44011502000975号
粤ICP备2022095718号
Wechat
